New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.

Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...

Guardant co-CEO Helmy Eltoukhy says the shift to personalized treatment and earlier diagnosis is here at the WIRED Health ...

Colorectal cancer was once considered primarily a disease of aging. But rates are now on the rise among younger adults. Since 2011, colon cancer rates among people younger than 50 have increased by ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for ...

AUSTIN (KXAN) – There is a new and less invasive option to test for colon cancer and it doesn’t require a stay at the hospital or mailing a stool sample. The Food Drug and Administration approved ...

Chaoyuan Kuang, MD, PhD, Co-Leader, GI Clinical and Translational Research, at Montefiore Einstein Comprehensive Cancer Center, and Othon Wiltz, MD, Colon and Rectal Surgeon, for Montefiore Einstein ...

A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...

(NEXSTAR) — An unexpected delivery at your door may not always be an unwelcome surprise — just ask one Kentucky boy about the thousands of dollars worth of lollipops that arrived at his home earlier ...

Jeff Smith was dumbfounded when he received a colon cancer screening kit in the mail. The 68-year-old Minnesota man hadn't asked for the Cologuard test, and his doctor hadn't mentioned anything about ...

Dr. Bethany Malone has treated a lot of colorectal cancer patients. The youngest, not counting those with genetic conditions, ...